Indicators

Markets:

News

Latest News about FATE

Recent news which mentions FATE

< Previous 1 2 3 4 5 Next >

Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022

June 03, 2022

‘The capitulation model for biotech is a Category 5 storm, the same as energy in 2020’ — why contrarians say the sector is a buy

May 20, 2022

Recap: Fate Therapeutics Q1 Earnings

May 04, 2022

The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints

May 04, 2022

These stocks soared during the pandemic, and then crashed. Ten are now expected to double in price.

May 02, 2022

What 4 Analyst Ratings Have To Say About Fate Therapeutics

March 04, 2022

Fate Therapeutics: Q4 Earnings Insights

February 28, 2022

Earnings Scheduled For February 28, 2022

February 28, 2022

The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight

February 27, 2022

Fate Therapeutics's Earnings: A Preview

February 25, 2022

Earnings Outlook For Fate Therapeutics

February 25, 2022

2 Natural-Killer Cell Therapy Oncology Companies Investors Should Watch

February 08, 2022

Benzinga Asks: Which ARK Fund Would You Rather Buy And Hold For 5 Years?

January 14, 2022

Here's How Much $100 Invested In Fate Therapeutics 5 Years Ago Would Be Worth Today

January 05, 2022

Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021

December 15, 2021

10 Biggest Price Target Changes For Wednesday

December 15, 2021

The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks

December 14, 2021

Fate Therapeutics Showcases Interim Data From FT596 Cell Program In Lymphoma

December 14, 2021

Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021

December 07, 2021

Cathie Wood Likes Fate Therapeutics, Should You?

December 01, 2021

3 Biotech Stocks That Can Double Your Money, According to Wall Street

November 25, 2021

Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2021

November 09, 2021

Fate Therapeutics, inc (FATE) Q3 2021 Earnings Call Transcript

November 05, 2021

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO

November 04, 2021

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

October 31, 2021

3 Biotech Stocks to Watch Now

October 12, 2021

Recent Poor Results Have Made This Promising Cathie Wood Pick a Bargain

September 14, 2021

Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021

August 26, 2021

58 Biggest Movers From Friday

August 23, 2021

12 Health Care Stocks Moving In Friday's Intraday Session

August 20, 2021

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.